← Eichor
Condition: Molecular Pathway Deregulation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Molecular Pathway Deregulation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population
Phase N/A · 1 location(s) · Liaquat University of Medical & Health Sciences · NCT06830590Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06363734Clinicopathological Characteristics of Colon Cancer in Young Age
Phase N/A · 1 location(s) · Seoul National University Bundang Hospital · NCT05365412Molecular Diagnosis of Systemic Autoinflammatory Diseases
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05364294Signal TrAnsduction Pathway Activity Analysis in OVarian cancER
Phase 2/Phase 3 · 6 location(s) · Gynaecologisch Oncologisch Centrum Zuid · NCT03458221
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.